Neurophysiologic Changes in Patients With Bipolar Depression

Status Recruiting

Clinical Trial Summary

- To examine differences in neurophysiologic parameters between unmedicated patients with bipolar depression and healthy controls

- To examine within-subject changes in neurophysiologic parameters in patients with bipolar depression treated with quetiapine

Clinical Trial Description

- Alterations of neurophysiologic regulation has been suggested in patients with major depressive disorder or bipolar disorders

- Depressive phase of bipolar disorder shows multi-faceted characteristics different from unipolar depression

- Quetiapine is an atypical antipsychotic licensed for treatment of bipolar depression

- The aim of this study is to investigate the pattern of neurophysiologic dysregulation in bipolar depression and its changes induced by quetiapine treatment ;

Study Design

Allocation: Non-Randomized, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Basic Science

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01213121
Study type	Interventional
Source	Seoul National University Bundang Hospital
Contact	Jae Seung Chang, M.D., Ph.D.
Phone	82-31-787-7437
Email	cjs0107@snu.ac.kr
Status	Recruiting
Phase	Phase 4
Start date	September 2010
Completion date	October 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03256162` - Ketamine as an Adjunctive Therapy for Major Depression	Phase 1
Recruiting	`NCT03396744` - Bright Light Therapy in the Treatment of Non-seasonal Bipolar Depression	Phase 1/Phase 2
Completed	`NCT01914393` - Pediatric Open-Label Extension Study	Phase 3
Active, not recruiting	`NCT03641300` - Efficacy of Convulsive Therapies for Bipolar Depression	N/A
Completed	`NCT02363738` - 12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression	Phase 2
Terminated	`NCT01807741` - Asenapine for Bipolar Depression	Phase 2
Completed	`NCT01919892` - Longitudinal Study on the Neuroprotective and Neurotrophic Effects of Lithium	Phase 4
Completed	`NCT00762268` - A Trial of SAMe for Treatment-Resistant Bipolar Depression	N/A
Terminated	`NCT00566111` - Ceftriaxone in the Management of Bipolar Depression	N/A
Terminated	`NCT00217217` - Low Field Magnetic Stimulation Treatment for Bipolar Depression	Phase 3
Recruiting	`NCT04998773` - Efficacy and Biomarkers of Response of TBS in Treatment Resistant Depression	N/A
Recruiting	`NCT04939649` - Ketamine as an Adjunctive Therapy for Major Depression (2)	Phase 3
Completed	`NCT03658824` - Behavioural Activation for Bipolar Depression: A Case Series	N/A
Suspended	`NCT03674671` - Ketamine Versus Electroconvulsive Therapy in Depression	Phase 3
Recruiting	`NCT05340686` - Braining- Aerobic Physical Activity as Add on Treatment in Bipolar Depression	N/A
Recruiting	`NCT05296356` - OSU6162 in Bipolar Depression (OBID)	Phase 2
Recruiting	`NCT03711019` - Efficacy of Convulsive Therapies During Continuation	N/A
Completed	`NCT02088580` - Feasibility and Tolerability of Adjunct Chronotherapy in Depressed Inpatients	N/A
Terminated	`NCT00272025` - Treatment Resistant Bipolar Depression	Phase 1
Completed	`NCT00566150` - Levetiracetam in the Management of Bipolar Depression	N/A